Infection with COVID-19 promotes the progression of pancreatic cancer through the PI3K-AKT signaling pathway

被引:0
|
作者
Xusheng Zhang
Bendong Chen
Kejun Liu
Yongxin Ma
Yimin Liu
Hongcai Zhou
Peng Wei
机构
[1] Ningxia Medical University,
[2] General Hospital of Ningxia Medical University,undefined
来源
Discover Oncology | / 14卷
关键词
COVID-19; Pancreatic cancer; Machine learning; PI3K-AKT signaling pathway; Support vector machine; Random forest tree;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway
    Na Li
    Fan Yang
    Dong-Yan Liu
    Jin-Tao Guo
    Nan Ge
    Si-Yu Sun
    World Journal of Gastrointestinal Oncology, 2021, (09) : 1164 - 1183
  • [22] AHNAK2 Promotes the Progression of Differentiated Thyroid Cancer through PI3K/AKT Signaling Pathway
    Xu, Min
    Wen, Jialiang
    Xu, Qiding
    Li, Huihui
    Lin, Bangyi
    Bhandari, Adheesh
    Qu, Jinmiao
    CURRENT CANCER DRUG TARGETS, 2024, 24 (02) : 220 - 229
  • [23] Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
    Han, Wei
    Wang, Nan
    Kong, Rui
    Bao, Wen
    Lu, Jie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [24] ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway
    Yu, Wenhao
    Zhang, Qi
    Ali, Muhammad
    Chen, Bangquan
    Sun, Qiannan
    Wang, Daorong
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (10) : 3786 - 3798
  • [25] TNFRSF11B promotes the progression of bladder cancer through PI3K/AKT signaling pathway
    Deng, Hao
    Ning, Jinzhuo
    Ruan, Yuan
    Yu, Weimin
    Cheng, Fan
    MOLECULAR AND CELLULAR PROBES, 2024, 78
  • [26] Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
    Wei Han
    Nan Wang
    Rui Kong
    Wen Bao
    Jie Lu
    Journal of Translational Medicine, 20
  • [27] Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway
    Qiao, Zhongshi
    Dai, Chengcheng
    Wang, Zhiqian
    Wang, Zifan
    Wang, Zheng
    Zhang, Tongsong
    Niu, Wenjing
    Ma, Xuezhen
    THORACIC CANCER, 2022, 13 (08) : 1117 - 1125
  • [28] Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway
    Lin, Miaomiao
    Xiao, Yanyi
    Dai, Yile
    Mao, Yefan
    Xu, Liming
    Zhang, Qiyu
    Chen, Zhe
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (04): : 951 - 965
  • [29] Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway
    Miaomiao Lin
    Yanyi Xiao
    Yile Dai
    Yefan Mao
    Liming Xu
    Qiyu Zhang
    Zhe Chen
    Clinical and Translational Oncology, 2024, 26 : 951 - 965
  • [30] Targeting the PI3K-Akt pathway in kidney cancer
    Park, Jin-Young
    Lin, Pei-Yin
    Weiss, Robert H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 863 - 870